4.67 Teclistimab for R/R Multiple Myeloma
Plenary Session - inactive due to federal service - Podcast tekijän mukaan Vinay Prasad, MD MPH
Kategoriat:
The drug has a high response rate and lots of infections, is it active? Yes; Efficacious? ???? I review ASCO2022 updates
